Immunologically effective dose: a practical model for immuno-radiotherapy

Oncotarget
Raphael SerreDominique Barbolosi

Abstract

Concomitant radiotherapy with immune checkpoint blockade could be synergistic. Out-of-field effects could improve survival by slowing or blocking metastatic spreading. However, not much is known about the optimal size per fraction and inter-fraction time in that new context. The new concept of Immunologically Effective Dose (IED) is proposed: it models an intrinsic immunogenicity of radiotherapy schedules, i.e. the fraction of immunogenicity that results from the choice of the dosing regimen. The IED is defined as the single dose, given in infinitely low dose rate, that produces the same amount of abscopal response as the radiation schedule being considered. The IED uses the classic parameters of the BED formula and adds two parameters for immunogenicity that describe the local availability of immune effectors within the tumor micro-environment. Fundamentally, the IED adds a time dimension in the BED formula and describes an intrinsic immunogenicity level for radiotherapy. The IED is positively related to the intensity of the out-of-field, radiotherapy-mediated, immune effects described in some preclinical data. Examples of numerical simulations are given for various schedules. A web-based calculator is freely available. Out-of...Continue Reading

References

Aug 1, 1989·The British Journal of Radiology·J F Fowler
Jul 4, 2009·The Lancet Oncology·Silvia C Formenti, Sandra Demaria
Aug 27, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·M Zahidunnabi DewanSandra Demaria
Jan 3, 2012·International Journal of Radiation Oncology, Biology, Physics·Dörthe SchaueWilliam H McBride
Mar 9, 2012·The New England Journal of Medicine·Michael A PostowJedd D Wolchok
Feb 25, 2014·Cancer Immunology Research·Encouse B GoldenSilvia C Formenti
Jun 16, 2016·Cancer Research·Raphael SerreDominique Barbolosi
Jul 6, 2016·Frontiers in Oncology·Lisa DelochUdo S Gaipl
Sep 24, 2016·Journal for Immunotherapy of Cancer·Josephine KangSilvia Formenti

❮ Previous
Next ❯

Citations

Jun 23, 2019·Cancers·Jihane BoustaniCéline Mirjolet
Jun 28, 2019·Nature Reviews. Clinical Oncology·Clemens GrassbergerJay S Loeffler
Jun 20, 2020·Clinical Pharmacology and Therapeutics·Sebastien Benzekry
Jan 8, 2020·Cancers·Julijan KabiljoMichael Bergmann
Apr 10, 2019·JCO Clinical Cancer Informatics·Juan Carlos López AlfonsoHeiko Enderling
Oct 24, 2019·Cancer Research·Pedro Rodríguez-BarbeitoJuan Pardo-Montero
Jul 18, 2020·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Wonmo SungHarald Paganetti
Nov 17, 2020·Oncoimmunology·Ben G L VannesteDirk De Ruysscher
Apr 3, 2021·Frontiers in Oncology·Thomas FriedrichMarco Durante
Jan 29, 2020·Annals of Oncology : Official Journal of the European Society for Medical Oncology·J CiccoliniF Barlesi

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cell Checkpoints & Regulators

Cell cycle checkpoints are a series of complex checkpoint mechanisms that detect DNA abnormalities and ensure that DNA replication and repair are complete before cell division. They are primarily regulated by cyclins, cyclin-dependent kinases, and the anaphase-promoting complex/cyclosome. Here is the latest research.

Related Papers

Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al]
Cédric Panje, Matthias Guckenberger
European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)
Antonin LevyÉ Deutsch
© 2022 Meta ULC. All rights reserved